Skip to content

Observational study to evaluate effectiveness of prophylactic cranial irradiation on patients with limited-stage small cell lung cancer.

Observational study to evaluate effectiveness of prophylactic cranial irradiation on patients with limited-stage small cell lung cancer. - Observational study of PCI on LS-SCLC

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000018253
Enrollment
98
Registered
2015-07-16
Start date
2015-07-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Limited-stage small cell lung cancer

Interventions

None listed

Sponsors

Hamamatsu Shizuoka Respiratory Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Histologically or cytologically confirmed small cell lung cancer in limited-stage (IA to IIIB) 2. Responded to first treatment to complete response or good partial response (short axis of all mediastinal lymphnodes <15mm, no persisting primary lesion) 3. Confirmed absence of brain metastasis with enhanced cranial MRI within 2 months after the finish of initial treatment

Exclusion criteria

Exclusion criteria: 1. Patients with brain metastasis 2. Patients judged as inappropriate for this study by investigators

Design outcomes

Primary

MeasureTime frame
Incidence of brain metastasis

Secondary

MeasureTime frame
Overall survival time, Quality of life (QCQ-C30/BN20), cognitive ability (MMSE)

Countries

Japan

Contacts

Public Contactkoji Nishimoto

Hamamatsu Univ. School of Medicine Department of Internal Medicine, second division

knishi@hama-med.ac.jp053-435-2263

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026